Primary Reperfusion Secondary Stenting Trial (PRIMACY)
Immediate vs. Delayed Stenting After Primary Percutaneous Reperfusion in ST Elevation Myocardial Infarction
Sponsor: Montreal Heart Institute
A NA clinical study on ST-elevation Myocardial Infarction, this trial is completed. The trial is conducted by Montreal Heart Institute and has accumulated 10 data snapshots since 2014. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
10 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Sep 2024 — Sep 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Sep 2020 — Jan 2021 [monthly]
Completed NA
▶ Show 5 earlier versions
-
Jun 2019 — Sep 2020 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Jun 2018 — Jun 2019 [monthly]
Active Not Recruiting NA
-
Sep 2017 — Jun 2018 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Aug 2017 — Sep 2017 [monthly]
Recruiting NA
Phase: PHASE3 → NA
-
Jan 2017 — Aug 2017 [monthly]
Recruiting PHASE3
First recorded
Apr 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Montreal Heart Institute
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Bastia, France , Cannes, France , Clermont-Ferrand, France , Le Coudray, France , Lyon, France , Metz-Tessy, France , Montpellier, France , Montreal, Canada , Nîmes, France , Pau, France and 4 more locations